Clinical Trial Update: Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial assessing aspirin for prevention of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Duke University | Conditions: Venous Thromboembolism, Ovarian Cancer | Phase 4 | Status: COMPLETED | Results posted: 2022-09-26